Literature DB >> 25323822

Synthesis and antitumor activity of natural compound aloe emodin derivatives.

Naraganahalli R Thimmegowda1, Chanmi Park, Bettaswamigowda Shwetha, Krisada Sakchaisri, Kangdong Liu, Joonsung Hwang, Sangku Lee, Sook J Jeong, Nak K Soung, Jae H Jang, In-Ja Ryoo, Jong S Ahn, Raymond L Erikson, Bo Y Kim.   

Abstract

In this study, we have synthesized novel water soluble derivatives of natural compound aloe emodin 4(a-j) by coupling with various amino acid esters and substituted aromatic amines, in an attempt to improve the anticancer activity and to explore the structure-activity relationships. The structures of the compounds were determined by (1) H NMR and mass spectroscopy. Cell growth inhibition assays revealed that the aloe emodin derivatives 4d, 4f, and 4i effectively decreased the growth of HepG2 (human liver cancer cells) and NCI-H460 (human lung cancer cells) and some of the derivatives exhibited comparable antitumor activity against HeLa (Human epithelial carcinoma cells) and PC3 (prostate cancer cells) cell lines compared to that of the parent aloe emodin at low micromolar concentrations.
© 2014 John Wiley & Sons A/S.

Entities:  

Keywords:  Hep G2 cells; NCI-H460 cells; aloe emodin; aloe emodin derivatives; antitumor activity; structure activity relationship

Mesh:

Substances:

Year:  2014        PMID: 25323822     DOI: 10.1111/cbdd.12448

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  2 in total

1.  Enhancement of oral bioavailability and anti-hyperuricemic activity of aloe emodin via novel Soluplus®-glycyrrhizic acid mixed micelle system.

Authors:  Feng Shi; Lin Chen; Yaping Wang; Jing Liu; Michael Adu-Frimpong; Hao Ji; Elmurat Toreniyazov; Qilong Wang; Jiangnan Yu; Ximing Xu
Journal:  Drug Deliv Transl Res       Date:  2021-04-15       Impact factor: 4.617

Review 2.  Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer.

Authors:  Gökçe Şeker Karatoprak; Esra Küpeli Akkol; Çiğdem Yücel; Özlem Bahadır Acıkara; Eduardo Sobarzo-Sánchez
Journal:  Oxid Med Cell Longev       Date:  2022-01-18       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.